Status
Conditions
About
To enhance understanding of supplemental oxygen-its utility in and adoption by patients with pulmonary fibrosis-by examining how patients perceive it and by determining how perceptions and patient-centered outcome measures change from before to after supplemental oxygen is prescribed.
Full description
The investigators aim to recruit patients with PF to participate in interviews and/or a one-year study of supplemental oxygen (O2). In the one-year study, the investigators will collect data before and for one year after PF patients are prescribed daily-use supplemental oxygen and compare outcomes, including shortness of breath, quality of life, fatigue, cough, and day-to-day functioning before and after O2.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Patient-Participants
(Using daily 02 therapy at time of enrollment)
(Not using daily 02 therapy at time of enrollment)
Primary Supporters
O2 Prescribers
Exclusion criteria
Patient-Participants (Using daily 02 therapy at time of enrollment)
(Not using daily 02 therapy at time of enrollment)
Primary Supporters • Not meeting inclusion criteria
O2 Prescribers
• Not meeting inclusion criteria
19 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal